References
- Danieli MG, Paoletti P, Recchioni A, Gabrielli A, Danieli G. Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vascu-litis. Scand J Rheumatol 1993;22: 215–9.
- Font J, Coca A, Molina R, Ballesta A, Cardellach F, Ingelmo M, et al. Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol 1986;15:201–5.
- Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1984;13:39–44.
- Borg EJ, Horst G, Limburg PC, Rijswijk MH, Kallenberg CGM. C-reactive protein levels during disease exacerbations and infections in Systemic Lupus Erythematosus: A prospec-tive longitudinal study. J Rheumatol 1990;17:1642–8.
- Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H, et al. Adult Still's disase: A multicenter survey of Japanese patients. J Rheumatol 1990;17:1058–63.
- Ota T, Higashi S, Suzuki H, Eto S. Increased serum ferritin levels in adult Still's disease. Lancet 1987;1:562–3.
- Nishiya K, Hashimoto K. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:39–44.
- Lim MK, Lee CK, Ju YS, Cho YS, Lee MS, Yoo B, et al. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001;20:89— 93.
- Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630–40.
- Nossent JC. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in Black Caribbean patients. Semin Arthritis Rheum 1993;23:16–21.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classi-fication of SLE. Arthritis Rheum 1982;25:1271–7.
- Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classi-fication of RA. Arthritis Rheum 1987;31: 315–24.
- Davis MJ, Dawes PT, Fowler PD, Sheeran TP, Shadforth MF, Ziade F, et al. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol 1990;29:111–5.
- Klockars M, Weber T, Tanner P, Hellstrom PE, Pettersson T. Pleural fluid ferritin concentrations in human disease. J Clin Pathol 1985;38:818–24.
- Nishiya K, Kawabata F, Ota Z. Elevated urinary ferritin in lupus nephritis. J Rheumatol 1989;16:1513–4.
- Hesselink DA, Aarden LA, Swaak AJG. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol 2003;32:151–5.
- Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983;130: 2651–5.
- Maury CPJ, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:146— 50.
- Spronk PE, Terborg EJ, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 1992;90:106 — 10.
- Swaak AJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 1996;25:233— 8.